GO:1903781 positive regulation of cardiac conduction: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903781 (positive regulation of cardiac conduction) describes any biological process that activates or increases the frequency, rate or extent of cardiac conduction, the cell-to-cell spread of electrical excitation through the heart.
• Cardiac conduction depends on gap junctions, ion channels and adhesion complexes; desmosomal adhesion directly regulates cardiomyocyte cohesion and gap junction organization, thereby influencing conduction.
• Neurohumoral pathways, including oxytocin-driven hypothalamus-brainstem-heart circuits, can modulate heart rate variability and thus positive regulation of cardiac conduction.
• Metabolic and fibrotic remodeling, such as RBMS1-dependent myocardial fibrosis or RCAN1-driven mitochondrial fission, can indirectly alter conduction by changing the myocardial substrate [1,5].
• G protein-coupled receptor kinase 3 (GRK3) phosphorylates cannabinoid receptor 2 and exacerbates diabetic heart injury, illustrating how kinase signaling can influence cardiac electrical behavior.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models are essential to test whether candidate genes causally regulate cardiac conduction.
Description
GO:1903781, positive regulation of cardiac conduction, is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate or extent of cardiac conduction. Cardiac conduction is the ordered propagation of electrical excitation through specialized cardiomyocytes and gap junctions, and its positive regulation is central to maintaining normal heart rhythm and output. Because conduction is a multicellular, adhesion-dependent process, its regulation integrates ion channel activity, gap junction coupling and structural adhesion complexes. Disruption of these regulatory mechanisms contributes to arrhythmias, heart failure and diabetic cardiomyopathy, making GO:1903781 a high-value term for cardiovascular research [1,5,7]. Recent work has also shown that neurohumoral circuits, including oxytocin-modulated hypothalamus-brainstem-heart pathways, can dynamically tune heart rate variability and conduction-related physiology. In addition, metabolic and fibrotic remodeling of the myocardium can indirectly affect conduction by altering the cellular substrate, as seen with RBMS1 deficiency improving myocardial fibrosis and heart failure. This article synthesizes authoritative GO annotation and verified PubMed literature to explain the mechanisms, key genes, disease links and research methods relevant to GO:1903781.
positive regulation of cardiac conduction At A Glance
| GO ID | GO:1903781 |
|---|---|
| GO term | positive regulation of cardiac conduction |
| Ontology | biological_process |
| Synonym | activation of cardiac conduction; up regulation of cardiac conduction; up-regulation of cardiac conduction; upregulation of cardiac conduction |
| Definition | Any process that activates or increases the frequency, rate or extent of cardiac conduction. |
| Major function | Enhances the frequency, rate or extent of electrical excitation spread through the heart, supporting coordinated contraction and rhythm. |
| Biological context | Cardiomyocyte gap junction coupling, ion channel activity, desmosomal adhesion and neurohumoral modulation. |
| Disease relevance | Arrhythmia, heart failure, diabetic cardiomyopathy and myocardial fibrosis. |
| Research tools | CRISPR knockout, point mutation, knock-in, overexpression, transcriptomics and functional electrophysiology. |
What Is GO:1903781?
In our own words, GO:1903781 refers to any biological process that activates or increases the frequency, rate or extent of cardiac conduction, the process by which electrical excitation spreads through the heart to trigger coordinated contraction. It is a positive regulatory biological_process term, meaning it describes an upstream or intrinsic mechanism that enhances conduction rather than the conduction event itself. Synonyms include activation of cardiac conduction, up regulation of cardiac conduction, up-regulation of cardiac conduction and upregulation of cardiac conduction.
Why Is positive regulation of cardiac conduction Important in Cell Biology?
Positive regulation of cardiac conduction is essential because the heart must reliably propagate electrical excitation to sustain rhythmic contraction and adequate cardiac output. When this regulation fails, the result can be arrhythmia, conduction block or heart failure, and metabolic stresses such as diabetes can further injure the myocardium through kinase signaling and mitochondrial dysfunction [5,7]. Understanding GO:1903781 therefore helps researchers identify causal genes, define disease mechanisms and develop targeted experimental models [1,8].
• Maintains normal heart rhythm by enhancing the frequency and rate of electrical conduction.
• Supports coordinated cardiomyocyte contraction and cardiac output.
• Links gap junction and desmosomal adhesion biology to electrical function.
• Provides a mechanistic framework for arrhythmia and conduction disease research.
• Connects neurohumoral modulation, such as oxytocin pathways, to heart rate variability.
• Relevant to diabetic cardiomyopathy through RCAN1 and GRK3 signaling [5,7].
• Relevant to myocardial fibrosis and heart failure through RBMS1.
• Guides CRISPR-based causal gene testing in cardiovascular research.
• Supports development of cell models for electrophysiology and transcriptomics.
• Helps interpret cardiovascular genetic and adiposity-related risk studies.
What Happens During positive regulation of cardiac conduction?
Initiation of electrical excitation and its enhancement
In simple terms: The heart starts an electrical signal, and positive regulation makes that signal fire more often or more strongly.
Positive regulation of cardiac conduction begins with processes that increase the frequency or rate of electrical excitation in cardiomyocytes. This can involve modulation of ion channel activity and membrane excitability, which determines how readily a cardiac action potential is initiated and propagated. Because the term is defined as any process that activates or increases the frequency, rate or extent of cardiac conduction, upstream signaling that enhances excitability falls within GO:1903781.
Cell-to-cell coupling through gap junctions
In simple terms: Heart muscle cells are connected by tiny channels that let the electrical signal pass directly from one cell to the next.
Cardiac conduction requires gap junctions that allow direct electrical coupling between cardiomyocytes, and regulation of gap junction organization is a key mechanism of positive regulation of cardiac conduction. Desmosomal adhesion regulates cardiac myocyte cohesion and gap junctions, meaning that adhesion complexes can influence how effectively excitation spreads. Enhancing gap junction coupling therefore increases the rate and extent of conduction.
Adhesion-dependent structural regulation
In simple terms: The physical connections between heart cells act like anchors that keep the electrical pathways working properly.
Desmosomal adhesion is a structural regulator of cardiac myocyte cohesion and gap junctions, and its modulation can affect conduction. Because gap junctions depend on proper cell-cell adhesion, changes in desmosomal components can alter the efficiency of electrical propagation. This places adhesion biology within the mechanistic scope of positive regulation of cardiac conduction.
Neurohumoral and autonomic modulation
In simple terms: Signals from the brain and hormones can speed up or tune the heart's electrical rhythm.
Oxytocin modulates respiratory heart rate variability through a hypothalamus-brainstem-heart neuronal pathway, demonstrating that neurohumoral circuits can regulate cardiac electrical behavior. Such pathways can influence the frequency and rate of conduction-related events, contributing to positive regulation of cardiac conduction. This highlights the integration of central nervous system and cardiac signaling in GO:1903781.
Metabolic and fibrotic modulation of the conduction substrate
In simple terms: Conditions like fibrosis or diabetes change the heart tissue, which can indirectly affect how electricity moves through it.
Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and heart failure, indicating that fibrotic remodeling can alter the myocardial substrate relevant to conduction. Suppression of RCAN1 alleviates lipid accumulation and mitochondrial fission in diabetic cardiomyopathy, linking metabolic stress to cardiomyocyte dysfunction that can affect conduction. G protein-coupled receptor kinase 3 exacerbates diabetic heart injuries through direct phosphorylation of cannabinoid receptor 2, showing that kinase signaling can influence cardiac injury and electrical behavior. These processes can indirectly modulate positive regulation of cardiac conduction by changing cardiomyocyte health and tissue architecture [1,5,7].
Key Genes Involved in GO:1903781 positive regulation of cardiac conduction
The following genes and proteins have been experimentally linked to cardiac conduction, cardiomyocyte coupling, or related cardiovascular regulatory processes that inform GO:1903781.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GJA1 | Gap junction channel protein mediating electrical coupling between cardiomyocytes | Central to cell-to-cell conduction; target for knockout and knock-in studies |
| GJA5 | Gap junction protein contributing to conduction in specialized myocardium | Candidate for point-mutation and overexpression studies |
| DSP | Desmosomal protein regulating cardiac myocyte cohesion and gap junctions | Directly linked to adhesion-dependent conduction regulation |
| DSG2 | Desmosomal cadherin involved in cardiomyocyte adhesion | Model for desmosome-gap junction crosstalk |
| DSC2 | Desmosomal cadherin contributing to cell cohesion | Target for knockout to test conduction effects |
| JUP | Desmosomal plaque protein linking adhesion to cytoskeleton | Relevant to adhesion-dependent conduction regulation |
| PKP2 | Desmosomal protein important for cardiac adhesion complexes | Model for arrhythmia-related conduction studies |
| RBMS1 | RNA-binding protein whose deficiency improves myocardial fibrosis and heart failure | Indirect modulator of conduction substrate |
| RCAN1 | Regulator of calcineurin signaling and mitochondrial fission | Linked to diabetic cardiomyopathy and cardiomyocyte dysfunction |
| GRK3 | G protein-coupled receptor kinase phosphorylating cannabinoid receptor 2 | Exacerbates diabetic heart injury; kinase signaling relevant to conduction |
| CNR2 | Cannabinoid receptor 2 phosphorylated by GRK3 | Target in diabetic heart injury models |
| OXT | Oxytocin, a neuropeptide modulating heart rate variability | Neurohumoral regulator of cardiac electrical behavior |
| OXTR | Oxytocin receptor mediating neurohumoral signaling | Candidate for modulation of conduction-related pathways |
| MDK | Midkine, a positive regulator of neovascularization in cardiovascular progenitors | Spatiotemporal transcriptomics candidate in cardiac biology |
| NPPA | Cardiac natriuretic peptide marker of cardiomyocyte stress | Readout in heart failure and conduction-related models |
| NPPB | Cardiac natriuretic peptide marker of heart failure | Readout in myocardial fibrosis and conduction studies |
| MYH7 | Cardiac myosin heavy chain | Structural cardiomyocyte marker in conduction models |
| TNNT2 | Cardiac troponin T | Contractile marker for cardiomyocyte function |
How Is positive regulation of cardiac conduction Regulated?
Positive regulation of cardiac conduction is regulated at multiple levels, including gap junction organization and desmosomal adhesion, which control cardiomyocyte cohesion and electrical coupling. Neurohumoral pathways such as oxytocin signaling through a hypothalamus-brainstem-heart circuit can modulate heart rate variability and thereby influence conduction-related physiology. Metabolic and stress-responsive signaling also contributes: RCAN1 suppression alleviates lipid accumulation and mitochondrial fission in diabetic cardiomyopathy, and GRK3 phosphorylates cannabinoid receptor 2 to exacerbate diabetic heart injury [5,7]. Fibrotic remodeling regulated by RBMS1 can further alter the myocardial substrate for conduction. Together, these mechanisms define a regulatory network that can positively or negatively tune cardiac conduction [1,4,5,7,8].
positive regulation of cardiac conduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GJA1 | Arrhythmia and conduction disorders | Knockout and knock-in cardiomyocyte models |
| DSP | Desmosome-related cardiac adhesion and conduction disease | Point-mutation and knockout models |
| RBMS1 | Myocardial fibrosis and heart failure | Knockout and overexpression models |
| RCAN1 | Diabetic cardiomyopathy | Knockout and overexpression models |
| GRK3 | Diabetic heart injury | Point-mutation and knockout models |
Arrhythmia and conduction disorders
Because positive regulation of cardiac conduction depends on gap junctions and desmosomal adhesion, disruption of these components can lead to arrhythmia and conduction disorders. Desmosomal adhesion regulates cardiac myocyte cohesion and gap junctions, and its impairment can destabilize electrical propagation. Research into GO:1903781 therefore directly informs the molecular basis of conduction disease.
Heart failure and myocardial fibrosis
Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and heart failure, indicating that fibrotic remodeling can alter the myocardial substrate relevant to conduction. Heart failure is associated with changes in cardiomyocyte structure and electrical behavior that can affect conduction. Studying positive regulation of cardiac conduction in this context may reveal targets that preserve electrical function.
Diabetic cardiomyopathy
Suppression of RCAN1 alleviates lipid accumulation and mitochondrial fission in diabetic cardiomyopathy, linking metabolic stress to cardiomyocyte dysfunction. G protein-coupled receptor kinase 3 exacerbates diabetic heart injuries through direct phosphorylation of cannabinoid receptor 2, showing that kinase signaling contributes to cardiac injury. These mechanisms can indirectly influence conduction and are relevant to GO:1903781 [5,7].
Cardiovascular risk and adiposity
Cardiovascular significance and genetics of epicardial and pericardial adiposity have been studied in large cohorts, highlighting how metabolic and fat-related traits relate to cardiac biology. Nutrition concepts for the treatment of obesity in adults further underscore the importance of metabolic management in cardiovascular health. These factors can indirectly affect the myocardial environment and conduction-related processes [2,3].
From positive regulation of cardiac conduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a gap junction gene reduce cardiac conduction? | CRISPR knockout in cardiomyocytes |
| Does a specific desmosomal mutation impair conduction? | Point-mutation knock-in model |
| Can a candidate gene enhance conduction when overexpressed? | Overexpression cell model |
| Does a disease-associated variant alter conduction-related signaling? | Knock-in of the variant |
| Which genes regulate fibrotic remodeling relevant to conduction? | RBMS1 knockout and overexpression |
| How does metabolic stress affect cardiomyocyte electrical behavior? | RCAN1 and GRK3 perturbation models [5,7] |
How to Study the positive regulation of cardiac conduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spatiotemporal transcriptomics | Gene expression across space and time | Discovering cardiac regulators such as Midkine |
| Functional electrophysiology | Electrical coupling and conduction velocity | Testing gap junction and ion channel genes |
| Gap junction imaging | Gap junction organization and localization | Assessing desmosome-gap junction crosstalk |
| Fibrosis phenotyping | Myocardial fibrosis and heart failure markers | RBMS1 deficiency models |
| Mitochondrial fission assays | Mitochondrial dynamics and lipid accumulation | RCAN1 suppression in diabetic cardiomyopathy |
| Kinase phosphorylation assays | Receptor phosphorylation status | GRK3-CNR2 signaling in diabetic heart injury |
| Heart rate variability analysis | Autonomic modulation of cardiac rhythm | Oxytocin pathway studies |
| Population genetics | Genetic associations with cardiac traits | Epicardial and pericardial adiposity studies |
Transcriptomics and spatiotemporal profiling
Spatiotemporal transcriptomics of human cardiovascular progenitors in pig hearts identified Midkine as a positive regulator of neovascularization, illustrating how transcriptomic approaches can discover regulators in cardiac biology. Such methods can be adapted to study genes that influence positive regulation of cardiac conduction. Combining spatial and temporal data helps map where and when conduction-related genes act.
Functional electrophysiology and gap junction assays
Because cardiac conduction depends on gap junctions and adhesion, functional assays that measure electrical coupling and cardiomyocyte cohesion are central to studying GO:1903781. Desmosomal adhesion regulation of gap junctions can be assessed by imaging and functional coupling assays. These methods directly test whether a candidate gene enhances or impairs conduction.
Disease model phenotyping
Models of myocardial fibrosis and heart failure, such as RBMS1 deficiency, can be phenotyped for conduction-related changes. Diabetic cardiomyopathy models involving RCAN1 and GRK3 can reveal metabolic effects on cardiac electrical behavior [5,7]. Neurohumoral models, including oxytocin pathway studies, can assess heart rate variability and conduction modulation.
Genetic and population-level analysis
Large-cohort studies of epicardial and pericardial adiposity provide genetic and cardiovascular context that can inform conduction research. Nutrition and obesity management literature highlights metabolic factors that indirectly affect cardiac health. Integrating population data with mechanistic experiments strengthens causal inference for GO:1903781 [2,3].
How CRISPR Can Be Used to Study GO:1903781 positive regulation of cardiac conduction
Knockout
CRISPR knockout of candidate genes such as GJA1, DSP or RBMS1 can test whether loss of function reduces positive regulation of cardiac conduction [1,8]. Knockout cardiomyocyte models allow direct assessment of gap junction coupling and electrical propagation. This approach is essential for establishing causal roles in GO:1903781.
Point Mutation
Point-mutation models can introduce disease-associated variants into genes such as DSP or GRK3 to test their effects on conduction-related signaling [7,8]. These models help distinguish pathogenic variants from benign polymorphisms. They are particularly useful for studying desmosomal and kinase-mediated mechanisms [7,8].
Knock-in
Knock-in of reporter tags or disease variants allows precise tracking of gene function in cardiomyocytes. Tagged knock-in models can reveal localization of gap junction and desmosomal proteins. This approach supports mechanistic studies of positive regulation of cardiac conduction.
Overexpression
Overexpression of candidate genes such as RCAN1 or RBMS1 can test whether increased activity enhances or disrupts conduction-related processes [1,5]. Overexpression models are useful for gain-of-function studies in GO:1903781 [1,5]. They complement knockout approaches to define bidirectional regulation [1,5].
How EDITGENE Supports positive regulation of cardiac conduction Research
Researchers studying positive regulation of cardiac conduction-related genes often need to determine whether a candidate gene is causally involved in electrical coupling, adhesion or metabolic modulation. EDITGENE provides publication-ready CRISPR cell models and screening services to accelerate this causal testing.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cardiac conduction research.
Frequently Asked Questions About positive regulation of cardiac conduction
What is GO:1903781?
GO:1903781 is the Gene Ontology term for positive regulation of cardiac conduction, defined as any process that activates or increases the frequency, rate or extent of cardiac conduction.
What is positive regulation of cardiac conduction?
It is the biological process that enhances the frequency, rate or extent of electrical excitation spread through the heart.
What genes are involved in positive regulation of cardiac conduction?
Genes involved include gap junction and desmosomal genes such as GJA1, GJA5, DSP, DSG2, DSC2, JUP and PKP2, as well as modulators like RBMS1, RCAN1 and GRK3 [1,5,7,8].
How does desmosomal adhesion affect cardiac conduction?
Desmosomal adhesion regulates cardiac myocyte cohesion and gap junctions, which are required for efficient electrical coupling and conduction.
Can neurohumoral signals regulate cardiac conduction?
Yes, oxytocin modulates respiratory heart rate variability through a hypothalamus-brainstem-heart neuronal pathway, showing neurohumoral regulation of cardiac electrical behavior.
What diseases are linked to impaired cardiac conduction?
Arrhythmia, conduction disorders, heart failure, myocardial fibrosis and diabetic cardiomyopathy are linked to impaired conduction-related processes [1,5,7,8].
How can CRISPR help study positive regulation of cardiac conduction?
CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate genes in conduction-related pathways [1,5,7,8].
What methods are used to study GO:1903781?
Methods include spatiotemporal transcriptomics, functional electrophysiology, gap junction imaging, fibrosis phenotyping and population genetics [1,3,4,5,6,7,8].
Is RBMS1 involved in cardiac conduction?
RBMS1 deficiency improves myocardial fibrosis and heart failure, which can indirectly affect the myocardial substrate relevant to conduction.
What is the role of GRK3 in diabetic heart injury?
GRK3 exacerbates diabetic heart injuries through direct phosphorylation of cannabinoid receptor 2, linking kinase signaling to cardiac injury.
Conclusion
GO:1903781, positive regulation of cardiac conduction, is a biologically important process that integrates gap junction coupling, desmosomal adhesion, neurohumoral modulation and metabolic signaling to enhance electrical propagation in the heart [4,8]. Its disruption is linked to arrhythmia, heart failure, myocardial fibrosis and diabetic cardiomyopathy, making it a key research area [1,5,7,8]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with transcriptomics and functional assays, provide the tools needed to identify causal regulators and translate findings into therapeutic strategies [1,5,6,7,8].
References
- 1. Li L et al.. 2026. Deficiency of the RNA-binding protein RBMS1 improves myocardial fibrosis and heart failure.. Eur Heart J 47(1):110-127 PMID: 40471706
- 2. Wiechert M et al.. 2021. Nutrition Concepts for the Treatment of Obesity in Adults.. Nutrients 14(1) PMID: 35011045
- 3. Rämö JT et al.. 2024. Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity.. JAMA Cardiol 9(5):418-427 PMID: 38477908
- 4. Buron J et al.. 2025. Oxytocin modulates respiratory heart rate variability through a hypothalamus-brainstem-heart neuronal pathway.. Nat Neurosci 28(11):2247-2261 PMID: 41116116
- 5. Shu S et al.. 2024. Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy.. Metabolism 158:155977 PMID: 39053690
- 6. Adusumalli S et al.. 2026. Spatiotemporal transcriptomics of human cardiovascular progenitors in pig hearts identifies Midkine as a positive regulator of neovascularization.. Nat Cardiovasc Res 5(8):744-762 PMID: 42538380
- 7. Gao P et al.. 2025. G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice.. Circulation 152(12):882-898 PMID: 40772312
- 8. Schinner C et al.. 2019. Regulation of cardiac myocyte cohesion and gap junctions via desmosomal adhesion.. Acta Physiol (Oxf) 226(2):e13242 PMID: 30582290
